参考文献/References:
[1] Garcia-Manero G. Myelodysplastic syndromes:2012 update on diagnosis,risk-stratification,and management[J].Am J Hematol,2012,87(7):692-701.
[2] Della Porta MG,Malcovati L,Strupp C,et al.Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome[J].Haematologica,2011,96(3):441-449.
[3] Jonas BA,Greenberg PL.MDS prognostic scoring systems-past,present,and future[J].Best Pract Res Clin Haematol,2015,28(1):3-13.
[4] Czader M,Orazi A.World Health Organization classification of myelodysplastic syndromes[J].Curr Pharm Des,2012,18(22):3149-3162.
[5] 张瑞妮,李 玲.骨髓增生异常综合征实验室检查及诊断技术的研究进展[J].白血病·淋巴瘤,2011,20(9):574-576.
Zhang RN,Li L.Advances of study on laboratory examination and diagnosis technology of myelodysplastic syndromes[J].Journal of Leukemia & Lymphoma,2011,20(9):574-576.
[6] Garcia-Manero G.Myelodysplastic syndromes:2015 Update on diagnosis,risk-stratification and management[J].Am J Hematol,2015,90(9):831-841.
[7] 韦 巍,韦常丽.细胞浆内含有Auer样杆状小体的骨髓瘤1例[J].现代检验医学杂志,2014,29(6):51.
Wei W,Wei CL.Auer rod like inclusions in multiple myeloma[J].JMod Lab Med,2014,29(6):51.
[8] 张延清,董家蔷,王京华,等.骨髓活检病理学检测在血液病诊断和鉴别诊断的价值[J].哈尔滨医科大学学报,2010,44(4):396-398.
Zhang YQ,Dong JQ,Wang JH,et al.Clinic value of bone marrow histopathology in diagnosis and differential diagnosis of hematonosis[J].Journal of Harbin Medical University,2010,44(4):396-398.
相似文献/References:
[1]韩秀蕊,杨娣娣,李艳春,等.多发性骨髓瘤患者骨髓涂片与骨髓活检同步检查的比较分析[J].现代检验医学杂志,2015,30(03):129.[doi:10.3969/j.issn.1671-7414.2015.03.039]
HAN Xiu-rui,YANG Di-di,LI Yan-chun,et al.Comparative Analysis of Bone Marrow Smears and Biopsies
Synchronous Check for Myeloma Patients[J].Journal of Modern Laboratory Medicine,2015,30(02):129.[doi:10.3969/j.issn.1671-7414.2015.03.039]
[2]韩秀蕊,杨娣娣,赵 园,等.281例骨髓增生异常综合征患者染色体核型分析及临床意义的研究[J].现代检验医学杂志,2015,30(04):91.[doi:10.3969/j.issn.1671-7414.2015.04.025]
HAN Xiu-rui,YANG Di-di,ZHAO Yuan,et al.Study on Chromosome Karyotype and Its Clinical
Significance in 281 Cases of Myelodysplastic Syndromes[J].Journal of Modern Laboratory Medicine,2015,30(02):91.[doi:10.3969/j.issn.1671-7414.2015.04.025]
[3]聂 群,陈卓诚a,聂李平a,等.自动血细胞分析参数对骨髓增生异常综合征和再生障碍性贫血的鉴别诊断价值[J].现代检验医学杂志,2017,32(05):74.[doi:10.3969/j.issn.1671-7414.2017.05.017]
NIE Qun,CHEN Zhuo-chenga,NIE Li-pinga,et al.Performance of Automatic Blood Cell Analysis Parameters for
Differential Diagnosis of Myelodysplastic Syndromes and Aplastic Anemia[J].Journal of Modern Laboratory Medicine,2017,32(02):74.[doi:10.3969/j.issn.1671-7414.2017.05.017]
[4]唐元艳,张利铭,张江召,等.骨髓增生异常综合征患者染色体异常与细胞形态学的相关性分析[J].现代检验医学杂志,2017,32(06):71.[doi:10.3969/j.issn.1671-7414.2017.06.001]
TANG Yuan-yan,ZHANG Li-ming,ZHANG Jiang-zhao,et al.Correlation between Chromosomal Abnormality
and Cell Morphology with Myelodysplastic Syndrome Patients[J].Journal of Modern Laboratory Medicine,2017,32(02):71.[doi:10.3969/j.issn.1671-7414.2017.06.001]
[5]张冬梅,万顺伦,于丽华.骨髓增生异常综合征患者外周血单个核细胞中OTC4,Gli1 基因的表达及与预后的COX 回归分析[J].现代检验医学杂志,2022,37(06):58.[doi:10.3969/j.issn.1671-7414.2022.06.011]
ZHANG Dong-mei,WANG Shun-lun,YU Li-hua.Expression of OTC4 and Gli1 Genes in Peripheral Blood Mononuclear Cells of Patients with Myelodysplastic Syndrome and Their Correlation with Prognosis by COX Regression Analysis[J].Journal of Modern Laboratory Medicine,2022,37(02):58.[doi:10.3969/j.issn.1671-7414.2022.06.011]
[6]张良子,左琴琴,吴大洲,等.1 例骨髓增生异常综合征多次受血患者血清存在抗-M,抗-cE 和抗-Jkb 抗体的鉴定及配血输血策略[J].现代检验医学杂志,2023,38(01):195.[doi:10.3969/j.issn.1671-7414.2023.01.037]
ZHANG Liang-zi,ZUO Qin-qin,WU Da-zhou,et al.Identification and Transfusion Strategy of Anti-M,Anti-cE and Anti-Jkb Antibodies in the Serum of Patients with Myelodysplastic Syndromes Receiving Multiple Blood Transfusions[J].Journal of Modern Laboratory Medicine,2023,38(02):195.[doi:10.3969/j.issn.1671-7414.2023.01.037]
[7]曲志梅,董 伟,刘艳萍.维奈克拉增强MDS 细胞系对地西他滨化疗敏感性机制的实验研究[J].现代检验医学杂志,2023,38(03):53.[doi:10.3969/j.issn.1671-7414.2023.03.010]
QU Zhi-mei,DONG Wei,LIU Yan-ping.Experimental Study on the Mechanism of Venetoclax Enhancing the Sensitivity of MDS Cell Lines to Decitabine Chemotherapy[J].Journal of Modern Laboratory Medicine,2023,38(02):53.[doi:10.3969/j.issn.1671-7414.2023.03.010]
[8]徐 娟a,贲海祥a,丁琳琳a,等.白细胞介素-1β 基因(rs16944)单核苷酸多态性与骨髓增生异常综合征易感性及临床特征的相关性研究[J].现代检验医学杂志,2023,38(04):51.[doi:10.3969/j.issn.1671-7414.2023.04.009]
XU Juana,BEN Haixianga,DING Linlina,et al.Study on the Relationship between Single Nucleotide Polymorphism of Interleukin-1β (rs16944) Gene and Susceptibility and Clinical Characteristics of Myelodysplastic Syndromes[J].Journal of Modern Laboratory Medicine,2023,38(02):51.[doi:10.3969/j.issn.1671-7414.2023.04.009]
[9]杨艳敏,郝秀君,赵志芳,等.骨髓增生异常综合征患者骨髓中ABAT mRNA表达和ABAT甲基化水平对预后预测价值研究[J].现代检验医学杂志,2024,39(06):84.[doi:10.3969/j.issn.1671-7414.2024.06.014]
YANG Yanmin,HAO Xiujun,ZHAO Zhifang,et al.Prognostic Value of ABAT mRNA Expression and ABAT Methylation Level in Bone Marrow of Patients with Myelodysplastic Syndrome[J].Journal of Modern Laboratory Medicine,2024,39(02):84.[doi:10.3969/j.issn.1671-7414.2024.06.014]